A detailed history of Cedrus LLC transactions in Amgen Inc stock. As of the latest transaction made, Cedrus LLC holds 945 shares of AMGN stock, worth $302,929. This represents 0.15% of its overall portfolio holdings.

Number of Shares
945
Previous 814 16.09%
Holding current value
$302,929
Previous $231 Million 27.58%
% of portfolio
0.15%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 24, 2024

BUY
$262.75 - $319.31 $34,420 - $41,829
131 Added 16.09%
945 $295 Million
Q1 2024

Apr 15, 2024

BUY
$268.87 - $324.56 $19,358 - $23,368
72 Added 9.7%
814 $231 Million
Q4 2023

Jan 26, 2024

BUY
$255.7 - $288.46 $189,729 - $214,037
742 New
742 $214 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cedrus LLC Portfolio

Follow Cedrus LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedrus LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedrus LLC with notifications on news.